Precipio Announces its Q2-2025 Financial Results
(NASDAQ:PRPO), NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company's financial performance and outlook for 2025. “Yet another quarter of revenue growth in both company divisions, along with overall gross margin improvement, has led […]